Loqtorzi Market Report 2026

Loqtorzi Market Overview

• The Loqtorzi market growth in the historic period has been driven by increasing npc diagnosis rates in endemic regions, advancements in immunotherapy research • Market expansion is supported by increasing global approvals for immunotherapy drugs, rising investment in rare cancer treatments • Growth Driver: Rising Prevalence Of Nasopharyngeal Carcinoma And Its Market Implications • Market Trend: Dr. Reddy's Laboratories Launches Biosimilar Of Loqtorzi For Nasopharyngeal Carcinoma In India • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Loqtorzi Market?

Loqtorzi (toripalimab-tpzi) is a PD-1 inhibitor biologic drug used for treating nasopharyngeal carcinoma (NPC), particularly in metastatic or recurrent cases. It enhances the immune system's ability to target and destroy cancer cells by blocking the PD-1 receptor on T-cells. The main formulations in the loqtorzi market are injectable formulation (intravenous) and lyophilized powder for reconstitution. Loqtorzi injectable formulation refers to the intravenous (IV) version of toripalimab (Loqtorzi), a monoclonal antibody used primarily in the treatment of certain cancers, including small cell lung cancer (SCLC) and nasopharyngeal carcinoma. The various indications include treatment of small cell lung cancer (SCLC) and treatment of other solid tumors. The patient population spans adults, geriatric patients, and pediatric patients. Distribution is carried out through multiple channels, including direct sales, wholesalers, distributors, retail pharmacies, and online pharmacies. End users of Loqtorzi include hospitals, oncology clinics, specialty pharmacies, and research institutions.

What Is The Loqtorzi Market Growth Forecast?

The growth in the forecast period can be attributed to increasing global approvals for immunotherapy drugs, rising investment in rare cancer treatments, expansion of oncology biologics access, growing use of combination immunotherapies, continued innovation in immune modulation therapies. Major trends in the forecast period include increasing adoption of pd-1 inhibitors in rare cancers, growing focus on nasopharyngeal carcinoma treatment, expansion of immuno-oncology pipelines, rising use of immune checkpoint blockade therapies, enhanced global clinical trial activity.

Global Loqtorzi Market Segmentation

1) By Formulation: Injectable Formulation (intravenous), Lyophilized Powder For Reconstitution 2) By Indication: Treatment Of Small Cell Lung Cancer (SCLC), Treatment Of Other Solid Tumors 3) By Patient Demographics: Adult Patients, Geriatric Patients, Pediatric Patients 4) By Distribution Channel: Direct Sales, Wholesalers and Distributors, Retail Pharmacies, Online Pharmacies 5) By End User: Hospitals, Oncology Clinics, Specialty Pharmacies, Research Institutions

What Is The Driver Of The Loqtorzi Market?

The rise in the prevalence of nasopharyngeal carcinoma is expected to propel the growth of the loqtorzi market going forward. Nasopharyngeal carcinoma is a type of cancer that affects the nasopharynx and is strongly linked to Epstein-Barr virus infection, with early diagnosis playing a key role in treatment outcomes. The rise in prevalence of nasopharyngeal carcinoma can be attributed to factors such as increased exposure to the Epstein-Barr virus, genetic predisposition, environmental factors such as tobacco and alcohol use, and dietary habits, particularly the consumption of salted and preserved food. Loqtorzi (toripalimab) helps nasopharyngeal carcinoma (NPC) patients by enhancing the immune system's ability to attack cancer cells through the inhibition of the PD-1 pathway, offering a novel treatment option for those with recurrent or metastatic NPC, either in combination with chemotherapy or as a monotherapy after disease progression. For instance, in October 2024, according to the Cancer Research UK, a UK-based registered charity, head and neck cancer incidence in the UK is expected to increase by 3% when comparing the period 2023–2025 with 2038–2040. Therefore, the rise in the prevalence of nasopharyngeal carcinoma is driving the growth of the loqtorzi industry.

Key Players In The Global Loqtorzi Market

Major companies operating in the loqtorzi market are Coherus BioSciences Inc., Shanghai Junshi Biosciences Co. Ltd.

Global Loqtorzi Market Trends and Insights

key trend in the loqtorzi market is focusing on developing biosimilars to expand its portfolio and offer cost-effective treatment alternatives to biologic therapies. Biosimilars are biologic products that are highly similar to an approved reference product, with no clinically meaningful differences in safety or effectiveness. They provide an affordable alternative to expensive biologic drugs once the original product's patent expires. For instance, in November 2024, Dr. Reddy's Laboratories, an India-based pharmaceutical company, launched a biosimilar of Coherus BioSciences' (CHRS) Loqtorzi (toripalimab) in India under the brand name Zytorvi. The drug is indicated for the treatment of adults with recurrent or metastatic nasopharyngeal carcinoma (RM-NPC), a rare form of cancer. Loqtorzi was FDA-approved in October 2023 for first-line treatment of RM-NPC in combination with cisplatin and gemcitabine and as a monotherapy for patients with disease progression after platinum-based chemotherapy. It is the only FDA-approved immuno-oncology drug for this indication.

What Are Latest Mergers And Acquisitions In The Loqtorzi Market?

In January 2024, Inovio Pharmaceuticals Inc., a US-based biotechnology company, partnered with Coherus BioSciences Inc. With this partnership, Inovio aims to advance the development of INO-3112 in combination with Loqtorzi (toripalimab-tpzi). This partnership focuses on treating patients with locoregionally advanced, high-risk, HPV16/18-positive oropharyngeal squamous cell carcinoma (OPSCC), a common form of throat cancer. This partnership aims to leverage the unique mechanisms of both therapies to improve clinical outcomes for patients with this type of throat cancer. Coherus BioSciences Inc. is a US-based biotech company, developing loqtorzi.

Regional Insights

North America was the largest region in the loqtorzi market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Loqtorzi Market?

The loqtorzi market consists of sales of diagnostic kits, biomarker assays, companion diagnostics, Loqtorzi-related drug delivery systems, and post-treatment care products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Loqtorzi Market Report 2026?

The loqtorzi market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the loqtorzi industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.